Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by [email protected] (Gustavo Barra) and Gustavo Barra. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by [email protected] (Gustavo Barra) and Gustavo Barra or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

️ 100: Epigenomic Diagnosis and Prognosis of Acute Myeloid Leukemia

14:44
 
Share
 

Manage episode 499155862 series 3682575
Content provided by [email protected] (Gustavo Barra) and Gustavo Barra. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by [email protected] (Gustavo Barra) and Gustavo Barra or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

️ Episode 100: Epigenomic Diagnosis and Prognosis of Acute Myeloid Leukemia

In this episode of PaperCast Base by Base, we explore a groundbreaking study that maps the epigenomic landscape of Acute Myeloid Leukemia (AML) and develops powerful diagnostic and prognostic tools for clinical use. The research introduces the Acute Leukemia Methylome Atlas (ALMA), integrating large-scale DNA methylation data, machine learning, and long-read sequencing to refine subtype classification and predict patient outcomes.

Study Highlights:

The authors harmonized DNA methylation profiles from 3,314 patient samples across 11 cohorts to build ALMA, an interactive atlas that visualizes hematopoietic heterogeneity and enables precise AML subtype classification. Using this resource, they developed two prognostic models: AML Epigenomic Risk, based on genome-wide methylation patterns, and a concise 38-CpG signature, both predicting five-year overall survival across pediatric and adult cohorts. They implemented a specimen-to-result protocol using nanopore sequencing, achieving high concordance between epigenomic predictions and genomic lesions, and demonstrated robustness across diverse clinical scenarios. While rare subtypes remain challenging due to limited training data, both models significantly outperformed current risk stratification systems.

Conclusion:

This work paves the way for faster, more affordable, and more accurate diagnosis and prognosis in AML, with potential to transform personalized treatment strategies.

Reference:

Marchi, F., Shastri, V. M., Marrero, R. J., Nguyen, N. H. K., Öttl, A., Schade, A-K., Landwehr, M., Krali, O., Nordlund, J., Ghavami, M., Sckaff, F., Mansinghka, V. K., Cao, X., Slayton, W., Starostik, P., Cogle, C. R., Ribeiro, R. C., Rubnitz, J. E., Klco, J., Elsayed, A., Gamis, A. S., Triche, T. J., Ries, R., Kolb, E. A., Aplenc, R., Alonzo, T., Pounds, S., Meshinchi, S., & Lamba, J. K. (2025). Epigenomic diagnosis and prognosis of Acute Myeloid Leukemia. Nature Communications, 16, 6961. https://doi.org/10.1038/s41467-025-62005-4

License:

This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/

On PaperCast Base by Base you’ll discover the latest in genomics, functional genomics, structural genomics, and proteomics.

  continue reading

122 episodes

Artwork
iconShare
 
Manage episode 499155862 series 3682575
Content provided by [email protected] (Gustavo Barra) and Gustavo Barra. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by [email protected] (Gustavo Barra) and Gustavo Barra or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

️ Episode 100: Epigenomic Diagnosis and Prognosis of Acute Myeloid Leukemia

In this episode of PaperCast Base by Base, we explore a groundbreaking study that maps the epigenomic landscape of Acute Myeloid Leukemia (AML) and develops powerful diagnostic and prognostic tools for clinical use. The research introduces the Acute Leukemia Methylome Atlas (ALMA), integrating large-scale DNA methylation data, machine learning, and long-read sequencing to refine subtype classification and predict patient outcomes.

Study Highlights:

The authors harmonized DNA methylation profiles from 3,314 patient samples across 11 cohorts to build ALMA, an interactive atlas that visualizes hematopoietic heterogeneity and enables precise AML subtype classification. Using this resource, they developed two prognostic models: AML Epigenomic Risk, based on genome-wide methylation patterns, and a concise 38-CpG signature, both predicting five-year overall survival across pediatric and adult cohorts. They implemented a specimen-to-result protocol using nanopore sequencing, achieving high concordance between epigenomic predictions and genomic lesions, and demonstrated robustness across diverse clinical scenarios. While rare subtypes remain challenging due to limited training data, both models significantly outperformed current risk stratification systems.

Conclusion:

This work paves the way for faster, more affordable, and more accurate diagnosis and prognosis in AML, with potential to transform personalized treatment strategies.

Reference:

Marchi, F., Shastri, V. M., Marrero, R. J., Nguyen, N. H. K., Öttl, A., Schade, A-K., Landwehr, M., Krali, O., Nordlund, J., Ghavami, M., Sckaff, F., Mansinghka, V. K., Cao, X., Slayton, W., Starostik, P., Cogle, C. R., Ribeiro, R. C., Rubnitz, J. E., Klco, J., Elsayed, A., Gamis, A. S., Triche, T. J., Ries, R., Kolb, E. A., Aplenc, R., Alonzo, T., Pounds, S., Meshinchi, S., & Lamba, J. K. (2025). Epigenomic diagnosis and prognosis of Acute Myeloid Leukemia. Nature Communications, 16, 6961. https://doi.org/10.1038/s41467-025-62005-4

License:

This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/

On PaperCast Base by Base you’ll discover the latest in genomics, functional genomics, structural genomics, and proteomics.

  continue reading

122 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play